Photo by gratisography.com
The Lilly Clinical Open Innovation (LCOI) blog, like much of the work we do in innovation, started as a thoughtful experiment. We believed that a blog would provide a great opportunity to openly explore clinical innovation topics and drive discussions around improving the patient experience. So in March of 2012, we launched the LCOI blog with the publication of our first post.
What was initially an experiment has turned into a wonderful and rewarding success! Since that first blog post over three years ago, we’ve published over 210 additional posts, while continuing to learn and evolve along the way. We’ve had many fantastic discussions with you, our audience, about how to improve the clinical trial experience for patients, meanwhile speeding innovation and scientific discovery. And we’re just getting started.
Hello, dear blog followers! Given your wonderful support of Lilly Clinical Open Innovation (LCOI), we wanted you to be the first to know that our blog is moving. More details about our move will be shared in a forthcoming blog post, but in the meantime, we’d like to share some highlights with you.
Next week the LCOI blog will be moved over to LillyPad, Lilly’s corporate blog. You will be able to find all of our posts, past and future, in LillyPad’s new Clinical Innovation section. Our Twitter handle will remain the same. As a blog subscriber, you should also know that you will no longer have the ability to subscribe to blogs via email, though we are looking to add that capability. To make sure that you are notified as new posts are published, we recommend that you subscribe to our RSS feed.
Thank you so much for the support you have shown LCOI. We look forward to expanding the conversation with you as we move to a new platform and begin this new chapter. See you next week at our new home!
Joseph Kim serves as a Senior Advisor in Clinical Development Innovation at Lilly, focusing on developing and implementing innovative patient engagement solutions. He has spent over 15 years in the Pharma industry utilizing a unique approach that integrates his experiences working for Sponsors such as Shire and Merck, CROs, and technology vendors.
Joseph has a robust combination of experience that includes early and late phase clinical research, and a well known history of innovation in the clinical research industry, recognized as one of “20 Innovators Changing the Face of the Clinical Trials Industry” by CenterWatch in 2013. He holds a BS in Molecular Biology from Lehigh University and an MBA from Villanova. He can be reached at email@example.com and on Twitter.
Tell us a little bit about yourself and how you got started in clinical research.
For starters, you should know that I did not come to clinical research through any natural career path. In fact, I had two other careers as a social worker and high school science teacher before landing in clinical research. My first role was as an entry level data manager. Quite comfortable with trying things on and pivoting quickly, my instinct was, “This isn’t for me either.” Given that I worked for a large pharma company (Merck), I was able to quickly learn about other roles and try them on too. My next move was as a garden variety study manager in psychiatric research. This was the old model, where it was you and a medical monitor doing everything from writing the protocol, to selecting sites, to reviewing data, to paying grants.
Reindeer Beagle by Mark Evans is licensed under CC-BY-2.0
Thank you to everyone who has made 2014 such a wonderful year! We have thoroughly enjoyed the conversations with you all and truly value your perspective. The Lilly Clinical Open Innovation (LCOI) team looks forward to continued interaction with you in 2015.
As we bring this year to a close, we’ve had some time to review our recent work, some of which we previously shared here on our blog. We sponsored a Patient Engagement App Challenge, which eventually led to the LVJJ website. The LVJJ website is a pilot project to improve how we present information to patients and caregivers on study websites. We’ve also progressed on our target profiles project, which is aimed at building a consistent framework for clinical trial eligibility criteria. And we created the Lilly Innovation Site Advocacy Group, providing us with access to great feedback from research sites.